Results 11 to 20 of about 147,146 (257)

Heart failure with reduced ejection fraction

Nature Reviews Disease Primers, 2017
Heart failure is a global public health problem that affects more than 26 million people worldwide. The global burden of heart failure is growing and is expected to increase substantially with the ageing of the population. Heart failure with reduced ejection fraction accounts for approximately 50% of all cases of heart failure in the United States and ...
Bloom, Michelle W., Greenberg, Barry H., Jaarsma, Tiny, Januzzi, J., Lam, Carolyn S.P., Maggioni, Aldo P., Trochu, Jean N., Butler, Javed   +7 more
exaly   +8 more sources

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes

ESC Heart Failure, 2023
Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF] 
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Yoko Omura‐Ohata, Masaki Matsubara, Ryo Koezuka, Michio Noguchi, Tsutomu Tomita, Yasuhide Asaumi, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda   +11 more
doaj   +1 more source

Vericiguat for Heart Failure with Reduced Ejection Fraction [PDF]

Current Cardiology Reports, 2021
AbstractPurpose of ReviewThe nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway plays an important role in the regulation of cardiovascular function, and it is disrupted in heart failure (HF), resulting in decreased protection against myocardial injury.
Lombardi C. M., Cimino G., Pagnesi M., Dell'Aquila A., Tomasoni D., Ravera A., Inciardi R., Carubelli V., Vizzardi E., Nodari S., Emdin M., Aimo A.   +11 more
openaire   +4 more sources

The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction

Cardiac Failure Review, 2022
Heart failure (HF) is a major health burden associated with significant morbidity and mortality. Approximately half of all HF patients have reduced ejection fraction (left ventricular ejection fraction
Rebecca C Gosling, Abdallah Al-Mohammad
doaj   +1 more source

Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction

ESC Heart Failure, 2023
Aims Left ventricular ejection fraction (LVEF) ≤ 40% is a well‐established risk factor for mortality after acute coronary syndromes (ACS). However, the long‐term prognostic impact of mildly reduced ejection fraction (EF) (LVEF 41–49%) after ACS remains ...
Remo H.M. Furtado, Marcela G. Juliasz, Felipe Y.J. Chiu, Livia B.C. Bastos, Talia F. Dalcoquio, Felipe G. Lima, Renato Rosa, Cesar A. Caporrino, Adriadne Bertolin, Paulo R.R. Genestreti, Andre S. Ribeiro, Maria Carolina Andrade, Roberto R.C.V. Giraldez, Luciano M. Baracioli, Thomas A. Zelniker, Jose C. Nicolau   +15 more
doaj   +1 more source

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj   +1 more source

Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction

ESC Heart Failure, 2021
Aims Congestive heart failure (CHF) and impaired renal function are two often co‐existing medical conditions and associated with adverse cardiovascular outcome.
Susanne Jung, Agnes Bosch, Julie Kolwelter, Kristina Striepe, Dennis Kannenkeril, Tizia Schuster, Christian Ott, Stephan Achenbach, Roland E. Schmieder   +8 more
doaj   +1 more source

Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction

BMC Cardiovascular Disorders, 2021
Background The aim of this study was to determine the difference in effects of beta-blockers on long-term clinical outcomes between ischemic heart disease (IHD) patients with mid-range ejection fraction (mrEF) and those with reduced ejection fraction ...
Jun Shitara, Ryo Naito, Takatoshi Kasai, Hirohisa Endo, Hideki Wada, Shinichiro Doi, Hirokazu Konishi, Shuta Tsuboi, Manabu Ogita, Tomotaka Dohi, Shinya Okazaki, Katsumi Miyauchi, Hiroyuki Daida   +12 more
doaj   +1 more source

Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review

Терапевтический архив, 2023
Heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction are associated with significant morbidity and mortality, as well as growing economic burden.
Igor V. Zhirov, Natalia V. Safronova, Sergey N. Tereshchenko   +2 more
doaj   +1 more source

Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction

Biomolecules, 2023
Vitamin D emerged as an important prognostic biomarker in heart failure (HF), with currently highly debated therapeutic implications. Several trials on vitamin D supplementation in HF showed improvements in left ventricular (LV) remodeling and function ...
Timea Magdolna Szabo, Előd Ernő Nagy, Ádám Kirchmaier, Erhard Heidenhoffer, Hunor-László Gábor-Kelemen, Marius Frăsineanu, Judit Cseke, Márta Germán-Salló, Attila Frigy   +8 more
doaj   +1 more source